<DOC>
	<DOCNO>NCT00617227</DOCNO>
	<brief_summary>The study base hypothesis decrease creatinine clearance may associate detectable vancomycin level patient enteral ( oral / vancomycin enema ) vancomyicn CDAD . The objective study see whether enteral vancomycin absorb inflamed GI mucosa CDAD , absorb , achieve measurable serum concentration .</brief_summary>
	<brief_title>Serum Vancomycin Levels Patients Receiving Enteral Vancomycin</brief_title>
	<detailed_description>Vancomycin large glycopeptide compound molecular weight 1450 Da . It appreciably absorb orally eliminate primarily via renal route . Enteral vancomycin therapy ( oral/intracolonic ) use inpatient severe Clostridium difficile associate colitis unable take oral metronidazole fail treatment metronidazole . Oral vancomycin detectable serum normal person , concentration therapeutic range may find patient colitis . There case report serum concentration within therapeutic range oral/intracolonic administration vancomycin , association renal failure . The use enteral vancomycin geriatric population variable creatinine clearance prompt u measure serum vancomycin level patient .</detailed_description>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Patients enteral vancomycin therapy Coadministration intravenous vancomycin therapy , intravenousvancomycin administration previous10 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Enteral vancomycin therapy , serum vancomycin level , renal failure</keyword>
</DOC>